All Stories

  1. Polymer-doxorubicin Conjugates: Redefining Chemotherapy for Breast Cancer
  2. In Silico Identification of Antihypertensive Phytoconstituents in Terminalia arjuna via Molecular Docking, MD Simulation, and DFT Analysis
  3. Revisiting Raynaud’s Phenomenon: Emerging Insights and Evolving Management Strategies
  4. Lifileucel Therapy for Metastatic Melanoma: Advancements in Tumor-infiltrating Lymphocyte-based Immunotherapy
  5. A Mini-review on Unlocking Cognitive Enhancement: An Innovative Strategy for Optimal Brain Functions
  6. Transforming Cancer Care: Genomic Profiling, AI, and Next-Generation Drug Delivery Systems
  7. Microemulsion Loaded Hydrogel as an Advanced Approach for Topical Delivery of Drug: A Brief Review
  8. Advances in Liquid Chromatography-Mass Spectrometry (LC-MS): Integration, Innovations, and Applications
  9. COPD at a Crossroads: Bridging Advances and Gaps with Precision Medicine and Prevention
  10. MPOX: A Re-Emerging Zoonotic Orthopoxvirus Threatening Global Health
  11. A Complete Sojourn of Monoclonal Antibodies: AI, Rare Diseases / Disorders and Immunotoxic Effects
  12. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies
  13. An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs (2018-2021)
  14. Narrative Testimony and Characteristics of Rottlerin for the Treatment of Various Kinds of Cancer
  15. Current Medicinal Insights on Synthetic Small Molecules and Natural Origin Products as PD-1/PD-L1 Inhibitors
  16. A Mini-review on Recent Strategies and Applications of Nanomedicines to Combat Antimicrobial Resistance
  17. Solid Lipid Nanoparticles (SLNs): Advancements in Modification Strategies Toward Drug Delivery Vehicle
  18. Current Trends in the Development of EGFR Inhibitors as Promising Anticancer Agents: Sar and Synthetic Studies from (2010-2020)
  19. Niosome: A Vesicular Drug Delivery Tool
  20. Resealed Erythrocytes: As A Drug Delivery Tool
  21. Synthetic and semi-synthetic drugs as promising therapeutic option for the treatment of COVID-19
  22. Searching for Potential HDAC2 Inhibitors: Structure-activity Relationship Studies on Indole-based Hydroxamic Acids as an Anticancer Agent
  23. The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical Studies